We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Topotecan in Patients With Refractory Acute Leukemia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00100477
First Posted: December 31, 2004
Last Update Posted: September 25, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Immunex Corporation
SmithKline Beecham
Amgen
Information provided by (Responsible Party):
VA Office of Research and Development
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2001
  Primary Completion Date: January 2001 (Final data collection date for primary outcome measure)